Sym004-induced EGFR elimination is associated with profound anti-tumor activity in EGFRvIII patient-derived glioblastoma models

por Keir, Stephen T., Chandramohan, Vidyalakshmi, Hemphill, Carlee D., Grandal, Michael M., Melander, Maria Carlsen, Pedersen, Mikkel W., Horak, Ivan D., Kragh, Michael, Desjardins, Annick, Friedman, Henry S., Bigner, Darell D.
Publicado 2018

The collagen receptor uPARAP/Endo180 as a novel target for antibody-drug conjugate mediated treatment of mesenchymal and leukemic cancers

por Nielsen, Christoffer Fagernæs, van Putten, Sander Maarten, Lund, Ida Katrine, Melander, Maria Carlsén, Nørregaard, Kirstine Sandal, Jürgensen, Henrik Jessen, Reckzeh, Kristian, Christensen, Kristine Rothaus, Ingvarsen, Signe Ziir, Gårdsvoll, Henrik, Jensen, Kamilla Ellermann, Hamerlik, Petra, Engelholm, Lars Henning, Behrendt, Niels
Publicado 2017